These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 11912569

  • 1. Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers.
    Post RM, Altshuler LL, Frye MA, Suppes T, Rush AJ, Keck PE, McElroy SL, Denicoff KD, Leverich GS, Kupka R, Nolen WA.
    Bipolar Disord; 2001 Oct; 3(5):259-65. PubMed ID: 11912569
    [Abstract] [Full Text] [Related]

  • 2. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
    Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM.
    Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
    [Abstract] [Full Text] [Related]

  • 3. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.
    Post RM, Leverich GS, Nolen WA, Kupka RW, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck P, Grunze H, Walden J, Stanley Foundation Bipolar Network.
    Bipolar Disord; 2003 Dec; 5(6):396-406. PubMed ID: 14636363
    [Abstract] [Full Text] [Related]

  • 4. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
    Altshuler LL, Post RM, Hellemann G, Leverich GS, Nolen WA, Frye MA, Keck PE, Kupka RW, Grunze H, McElroy SL, Sugar CA, Suppes T.
    J Clin Psychiatry; 2009 Apr; 70(4):450-7. PubMed ID: 19358785
    [Abstract] [Full Text] [Related]

  • 5. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
    Post RM, Altshuler LL, Leverich GS, Frye MA, Nolen WA, Kupka RW, Suppes T, McElroy S, Keck PE, Denicoff KD, Grunze H, Walden J, Kitchen CM, Mintz J.
    Br J Psychiatry; 2006 Aug; 189():124-31. PubMed ID: 16880481
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
    Vieta E, Martinez-Arán A, Goikolea JM, Torrent C, Colom F, Benabarre A, Reinares M.
    J Clin Psychiatry; 2002 Jun; 63(6):508-12. PubMed ID: 12088162
    [Abstract] [Full Text] [Related]

  • 7. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Jun; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
    McGirr A, Vöhringer PA, Ghaemi SN, Lam RW, Yatham LN.
    Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
    [Abstract] [Full Text] [Related]

  • 9. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 10. Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients.
    Erfurth A, Michael N, Stadtland C, Arolt V.
    Neuropsychobiology; 2002 Apr; 45 Suppl 1():33-6. PubMed ID: 11893875
    [Abstract] [Full Text] [Related]

  • 11. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study.
    Amsterdam JD, Shults J.
    Int Clin Psychopharmacol; 2005 Sep; 20(5):257-64. PubMed ID: 16096516
    [Abstract] [Full Text] [Related]

  • 12. Utility of the daily prospective National Institute of Mental Health Life-Chart Method (NIMH-LCM-p) ratings in clinical trials of bipolar disorder.
    Denicoff KD, Ali SO, Sollinger AB, Smith-Jackson EE, Leverich GS, Post RM.
    Depress Anxiety; 2002 Sep; 15(1):1-9. PubMed ID: 11816046
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of adjunctive antidepressant treatment for bipolar depression.
    Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME.
    N Engl J Med; 2007 Apr 26; 356(17):1711-22. PubMed ID: 17392295
    [Abstract] [Full Text] [Related]

  • 14. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.
    Altshuler LL, Suppes T, Black DO, Nolen WA, Leverich G, Keck PE, Frye MA, Kupka R, McElroy SL, Grunze H, Kitchen CM, Post R.
    Am J Psychiatry; 2006 Feb 26; 163(2):313-5. PubMed ID: 16449487
    [Abstract] [Full Text] [Related]

  • 15. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.
    Eur Neuropsychopharmacol; 2008 Jul 26; 18(7):535-49. PubMed ID: 18501566
    [Abstract] [Full Text] [Related]

  • 16. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
    Amsterdam JD, Lorenzo-Luaces L, Soeller I, Li SQ, Mao JJ, DeRubeis RJ.
    J Affect Disord; 2015 Oct 01; 185():31-7. PubMed ID: 26143402
    [Abstract] [Full Text] [Related]

  • 17. Venlafaxine monotherapy in women with bipolar II and unipolar major depression.
    Amsterdam JD, Garcia-España F.
    J Affect Disord; 2000 Sep 01; 59(3):225-9. PubMed ID: 10854639
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA, LamLit Study Group.
    J Clin Psychiatry; 2009 Feb 01; 70(2):223-31. PubMed ID: 19200421
    [Abstract] [Full Text] [Related]

  • 19. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ghaemi SN, Whitham EA, Vohringer PA, Barroilhet SA, Amerio A, Sverdlov O, Patkar AA.
    J Clin Psychiatry; 2021 Jan 12; 82(1):. PubMed ID: 33434956
    [Abstract] [Full Text] [Related]

  • 20. Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison.
    Altshuler LL, Sugar CA, McElroy SL, Calimlim B, Gitlin M, Keck PE, Aquino-Elias A, Martens BE, Fischer EG, English TL, Roach J, Suppes T.
    Am J Psychiatry; 2017 Mar 01; 174(3):266-276. PubMed ID: 28135846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.